- 질문내용 -
I've been cut off reviews of silagra Alexion specializes in treatments for very rare diseases - amarket niche that has become popular with pharmaceuticalcompanies seeking products for which they can charge very highprices. Drugs for rare diseases can command prices of more than$500,000 a year, and have been highly profitable for otherbiotech companies.
|
|
